The effects of 4‐aminopyridine in multiple sclerosis patients: Results of a randomized, placebo‐controlled, double‐blind, concentration‐controlled, crossover trial CT Bever Jr, MD, D Young, PA Anderson, A Krumholz, K Conway, J Leslie, ... Neurology 44 (6), 1054-1054, 1994 | 213 | 1994 |
Pharmacometrics: a multidisciplinary field to facilitate critical thinking in drug development and translational research settings JS Barrett, MJ Fossler, KD Cadieu, MR Gastonguay The Journal of Clinical Pharmacology 48 (5), 632-649, 2008 | 173 | 2008 |
A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe … N Singla, HS Minkowitz, DG Soergel, DA Burt, RA Subach, MY Salamea, ... Journal of pain research, 2413-2424, 2017 | 162 | 2017 |
A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms A Zajicek, MJ Fossler, JS Barrett, JH Worthington, R Ternik, G Charkoftaki, ... The AAPS journal 15, 1072-1081, 2013 | 142 | 2013 |
Effects of the novel long-acting GLP-1 agonist, albiglutide, on cardiac function, cardiac metabolism, and exercise capacity in patients with chronic heart failure and reduced … JJ Lepore, E Olson, L Demopoulos, T Haws, Z Fang, AM Barbour, ... JACC: Heart Failure 4 (7), 559-566, 2016 | 138 | 2016 |
Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study JW Hainer, JS Barrett, CA Assaid, MJ Fossler, DS Cox, T Leathers, ... Thrombosis and haemostasis 87 (05), 817-823, 2002 | 130 | 2002 |
Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults D Menon-Andersen, JT Mondick, B Jayaraman, PA Thompson, ... Cancer chemotherapy and pharmacology 63, 229-238, 2009 | 108 | 2009 |
Hospitalized patients with and without hemodialysis have markedly different vancomycin pharmacokinetics: a population pharmacokinetic model-based analysis V Goti, A Chaturvedula, MJ Fossler, S Mok, JT Jacob Therapeutic drug monitoring 40 (2), 212-221, 2018 | 79 | 2018 |
Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations GS Rekhi, ND Eddington, MJ Fossler, P Schwartz, LJ Lesko, ... Pharmaceutical Development and Technology 2 (1), 11-24, 1997 | 58 | 1997 |
Benefit and risk evaluation of biased μ-receptor agonist oliceridine versus morphine A Dahan, CJ van Dam, M Niesters, M van Velzen, MJ Fossler, ... Anesthesiology 133 (3), 559-568, 2020 | 55 | 2020 |
Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6 D Young, KK Midha, MJ Fossler, EM Hawes, JW Hubbard, G McKay, ... European journal of clinical pharmacology 44, 433-438, 1993 | 54 | 1993 |
Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets ND Eddington, M Ashraf, LL Augsburger, JL Leslie, MJ Fossler, LJ Lesko, ... Pharmaceutical development and technology 3 (4), 535-547, 1998 | 52 | 1998 |
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3 {4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a … M Qian, SA Bai, B Brogdon, JT Wu, RQ Liu, MB Covington, K Vaddi, ... Drug metabolism and disposition 35 (10), 1916-1925, 2007 | 49 | 2007 |
Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis JW Hainer, DJ Sherrard, SK Swan, JS Barrett, CA Assaid, MJ Fossler, ... American journal of kidney diseases 40 (3), 531-538, 2002 | 49 | 2002 |
Oliceridine (TRV130), a novel G protein–biased ligand at the μ‐opioid receptor, demonstrates a predictable relationship between plasma concentrations and pain relief. I … MJ Fossler, BM Sadler, C Farrell, DA Burt, M Pitsiu, F Skobieranda, ... The Journal of Clinical Pharmacology 58 (6), 750-761, 2018 | 42 | 2018 |
Modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks SH Haidar, SB Johnson, MJ Fossler, AS Hussain Pharmaceutical research 19, 87-91, 2002 | 42 | 2002 |
Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphate MW Kemp, M Saito, H Usuda, TJ Molloy, Y Miura, S Sato, S Watanabe, ... American journal of obstetrics and gynecology 215 (6), 775. e1-775. e12, 2016 | 38 | 2016 |
Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers AM Barbour, L Sarov‐Blat, G Cai, MJ Fossler, DL Sprecher, J Graggaber, ... British Journal of Clinical Pharmacology 76 (1), 99-106, 2013 | 36 | 2013 |
Evaluating the incidence of opioid-induced respiratory depression associated with oliceridine and morphine as measured by the frequency and average cumulative duration of … S Ayad, MA Demitrack, DA Burt, C Michalsky, L Wase, MJ Fossler, ... Clinical Drug Investigation 40, 755-764, 2020 | 33 | 2020 |
Edible cannabis products: it is time for FDA oversight. DM Benjamin, MJ Fossler Journal of clinical pharmacology 56 (9), 2016 | 32 | 2016 |